Evidence map›Paper›PMID 31533499›Full record

ArticleJournal of the American Heart Association2019

Dimethylguanidino Valerate: A Lifestyle-Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality.

Filip Ottosson, Ulrika Ericson, Peter Almgren, Einar Smith, Louise Brunkwall, Sophie Hellstrand, Peter M Nilsson, Marju Orho-Melander, Céline Fernandez, Olle Melander

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Gut microbiota-associated metabolites and risk of ischemic stroke in REGARDS.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Filip OttossonDepartment of Clinical Sciences Lund University Malmö Sweden.
Ulrika EricsonDepartment of Clinical Sciences Lund University Malmö Sweden.
Peter AlmgrenDepartment of Clinical Sciences Lund University Malmö Sweden.
Einar SmithDepartment of Clinical Sciences Lund University Malmö Sweden.
Louise BrunkwallDepartment of Clinical Sciences Lund University Malmö Sweden.
Sophie HellstrandDepartment of Clinical Sciences Lund University Malmö Sweden.
Peter M NilssonDepartment of Clinical Sciences Lund University Malmö Sweden.
Marju Orho-MelanderDepartment of Clinical Sciences Lund University Malmö Sweden.
Céline FernandezDepartment of Clinical Sciences Lund University Malmö Sweden.
Olle MelanderDepartment of Clinical Sciences Lund University Malmö Sweden.
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Identification of lifestyle modifiable metabolic pathways related to cardiometabolic disease risk is essential for improvement of primary prevention in susceptible individuals. It was recently shown that plasma dimethylguanidino valerate (DMGV) levels are associated with incident type 2 diabetes mellitus. Our aims were to investigate whether plasma DMGV is related to risk of future coronary artery disease and with cardiovascular mortality and to replicate the association with type 2 diabetes mellitus and pinpoint candidate lifestyle interventions susceptible to modulate DMGV levels. Methods and Results Plasma DMGV levels were measured using liquid chromatography-mass spectrometry in a total of 5768 participants from the MDC (Malmö Diet and Cancer Study-Cardiovascular Cohort), MPP (Malmö Preventive Project), and MOS (Malmö Offspring Study). Dietary intake assessment was performed in the MOS. Baseline levels of DMGV associated with incident coronary artery disease in both the MDC (hazard ratio=1.29; CI=1.16-1.43;

Indexed as

Life StyleAdultAgedBiomarkersCase-Control StudiesCause of DeathCoronary Artery DiseaseCross-Sectional StudiesDiabetes Mellitus, Type 2ExerciseFemaleGuanidinesHumansIncidenceMaleMiddle AgedBiomarkersdimethylguanidino valerateGuanidinesValeratescoronary artery diseasediabetes mellituslifestylemetabolomemetabolomics

Identifiers

PMID31533499
PMCPMC6806048
OpenAlexW2974778669

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.